Anavex Life Sciences (AVXL) EBT Growth (3y) (2019 - 2025)
Anavex Life Sciences (AVXL) EBT Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 9.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 40.43% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.16% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Anavex Life Sciences | 229.83 Mn | 98.08 Mn | - | -481.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -481.56% |
| Sep 30, 2025 | -1,313.03% |
| Jun 30, 2025 | -69.95% |
| Mar 31, 2025 | -70.01% |
| Dec 31, 2024 | -96.79% |
| Sep 30, 2024 | -0.85% |
| Jun 30, 2024 | -6.45% |
| Mar 31, 2024 | -8.58% |
| Dec 31, 2023 | -3.07% |
| Sep 30, 2023 | -19.68% |
| Jun 30, 2023 | -20.14% |
| Mar 31, 2023 | -21.74% |
| Dec 31, 2022 | -25.44% |
| Sep 30, 2022 | -35.98% |
| Jun 30, 2022 | -23.60% |
| Mar 31, 2022 | -13.08% |
| Dec 31, 2021 | -16.23% |
| Sep 30, 2021 | -27.25% |
| Jun 30, 2021 | -52.88% |
| Mar 31, 2021 | -19.96% |